Biocryst Pharmaceuticals Balance Sheet (2010-2026) | BCRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	4.35M	199.60M	504.39M	3.35M	1.45M	246.90M	1.47M	155.14M	146.22M	150.91M	110.64M	84.33M	1.79M	96.84M	104.71M	0.29M	0.49M	84.08M	89.74M	171.59M
Short-term Investments (Quarter)	8.11M		3.21M	47.96M	144.91M	179.96M	119.54M	243.02M	264.45M	246.69M	278.34M	252.22M	193.62M	233.17M	216.14M	189.90M	172.00M	128.79M	185.01M	66.81M
Cash & Current Investments (Quarter)	12.46M	199.60M	507.60M	51.32M	146.36M	426.86M	121.02M	398.16M	410.67M	397.59M	388.99M	336.55M	195.41M	330.01M	320.85M	190.19M	172.50M	212.87M	274.75M	238.40M
Receivables - Net (Quarter)	6.51M	22.89M	27.38M	36.41M	41.49M	42.61M	50.60M	1.09M	57.67M	1.68M	56.95M	60.59M	66.29M	72.46M	0.56M	93.39M	3.22M	3.14M	92.35M	109.27M
Receivables - Other (Quarter)
Receivables (Quarter)	6.51M	22.89M	27.38M	36.41M	41.49M	42.61M	50.60M	1.09M	57.67M	1.68M	56.95M	60.59M	66.29M	72.46M	0.56M	93.39M	3.22M	3.14M	92.35M	109.27M
Work In Process (Quarter)
Inventory (Quarter)	9.85M	14.09M	15.79M	16.14M	23.38M	27.02M	27.53M	27.47M	27.03M	29.63M	28.68M	29.78M	4.45M	7.56M	8.09M	6.87M	5.04M	5.23M	5.40M	5.99M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	5.56M	8.97M	9.99M	12.33M	11.05M	11.07M	12.59M	15.16M	14.11M	20.02M	19.54M	18.38M	16.43M	16.28M	13.75M	14.33M	12.54M	16.50M	17.18M	19.11M
Current Assets (Quarter)	265.80M	252.74M	566.14M	511.71M	494.85M	509.00M	516.50M	490.88M	511.06M	502.47M	495.97M	447.10M	363.46M	427.12M	421.97M	409.98M	398.46M	355.68M	404.35M	373.62M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	7.67M	7.83M	8.71M	8.80M	8.70M	8.46M	8.62M	8.38M	8.44M	9.00M	7.91M	7.83M	7.66M	7.42M	7.78M	7.59M	8.46M	8.40M	8.78M	9.37M
Long-Term Investments (Quarter)			6.83M			34.33M	18.08M	3.43M	3.44M				64.32M	19.43M	20.32M	20.55M	10.10M	39.67M	61.16M	20.57M
Other Non-Current Assets (Quarter)	3.81M	5.19M	6.47M	7.21M	6.98M	6.80M	6.81M	7.05M	6.95M	11.46M	1.80M	12.96M	12.46M	2.22M	5.16M	4.85M	3.59M	4.39M	5.67M	19.70M
Non-Current Assets (Quarter)	11.48M	13.02M	22.02M	16.01M	15.69M	49.59M	33.50M	18.85M	18.83M	20.46M	20.99M	20.79M	108.96M	64.13M	68.45M	70.07M	58.73M	90.74M	109.81M	91.43M
Assets (Quarter)	277.28M	265.76M	588.15M	527.72M	510.54M	558.59M	550.00M	509.74M	529.88M	522.92M	516.96M	467.89M	472.42M	491.25M	490.42M	480.05M	457.19M	446.42M	514.16M	465.05M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	10.09M	19.69M	27.81M	13.88M	12.02M	8.62M	14.36M	6.25M	13.89M	10.57M	20.89M	11.91M	7.79M	13.48M	11.64M	10.05M	8.59M	5.57M	15.83M	10.96M
Notes Payables (Quarter)	30.00M	30.00M
Payables (Quarter)	40.09M	49.69M	27.81M	13.88M	12.02M	8.62M	14.36M	6.25M	13.89M	10.57M	20.89M	11.91M	7.79M	13.48M	11.64M	10.05M	8.59M	5.57M	15.83M	10.96M
Accumulated Expenses (Quarter)	48.77M	56.31M	72.67M	63.58M	79.71M	69.27M	87.56M	75.21M	75.30M	77.39M	102.88M	79.25M	89.60M	104.20M	113.29M	92.64M	107.11M	118.78M	126.41M	119.40M
Other Accumulated Expenses (Quarter)			3.68M
Short term Debt (Quarter)											23.57M	26.02M	28.97M	33.00M	32.68M	34.30M	35.74M	37.69M	38.45M	40.32M
Current Leases (Quarter)	0.98M	1.45M	1.82M	2.08M	2.13M	2.20M	1.52M	2.49M	2.53M	2.28M	1.59M	1.64M	1.68M	1.05M	1.83M	1.79M	1.62M	1.44M	0.32M	1.24M
Current Taxes (Quarter)			2.62M
Current Deferred Revenue (Quarter)	0.55M	0.60M	1.42M	1.47M	1.52M	1.55M	1.22M	1.20M	1.78M	0.52M										5.41M
Total Current Liabilities (Quarter)	115.60M	133.61M	103.72M	81.02M	95.39M	81.64M	105.51M	85.16M	93.50M	90.76M	149.99M	119.92M	129.06M	153.57M	160.38M	139.85M	177.16M	190.24M	196.07M	195.39M
Non-Current Liabilities
Capital Leases (Quarter)	4.10M	5.04M					1.78M				2.85M	2.51M	2.12M	2.08M	2.12M	2.31M	2.04M	1.74M	1.44M	1.17M
Non-Current Debt (Quarter)	126.80M	132.05M	136.08M	140.24M	144.52M	223.87M	231.62M	232.52M	293.18M	298.00M	303.23M	308.48M	313.82M	314.33M	314.87M	315.41M	242.79M	194.37M		395.20M
Non-Current Deffered Revenue (Quarter)																				8.83M
Liabilities from Discontinued Operations (Quarter)																	0.45M	0.44M
Operating Leases (Quarter)			5.96M	6.46M	8.33M	8.16M	4.03M	5.93M	8.33M	12.25M	9.45M	8.60M	8.36M	8.06M	8.86M	7.78M	8.88M	8.43M	8.57M	12.98M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)
Total Liabilities (Quarter)	383.36M	412.81M	695.14M	691.93M	723.77M	801.25M	844.60M	838.02M	918.60M	933.91M	972.49M	944.06M	948.02M	959.82M	966.35M	931.97M	878.78M	834.31M	633.31M	1,018.89M
Shareholder's Equity
Total Debt (Quarter)	126.80M	132.05M	136.08M	140.24M	144.52M	223.87M	231.62M	232.52M	293.18M	298.00M	326.80M	334.51M	342.80M	347.33M	347.55M	349.72M	278.54M	232.05M	38.45M	435.51M
Common Equity (Quarter)	-106.08M	-147.04M	-106.99M	-164.22M	-213.23M	-242.66M	-294.60M	-328.29M	-388.71M	-410.99M	-455.53M	-476.17M	-475.61M	-468.56M	-475.93M	-451.93M	-421.59M	-387.89M	-119.15M	-553.84M
Shareholder's Equity (Quarter)	-106.08M	-147.04M	-106.99M	-164.22M	-213.23M	-242.66M	-294.60M	-328.29M	-388.71M	-410.99M	-455.53M	-476.17M	-475.61M	-468.56M	-475.93M	-451.93M	-421.59M	-387.89M	-119.15M	-553.84M
Liabilities and Shareholders Equity (Quarter)	277.28M	265.76M	588.15M	527.72M	510.54M	558.59M	550.00M	509.74M	529.88M	522.92M	516.96M	467.89M	472.42M	491.25M	490.42M	480.05M	457.19M	446.42M	514.16M	465.05M
Retained Earnings (Quarter)	0.09M	-1189.72M	-1207.50M	-1281.70M	-1340.56M	-0.10M	0.03M	0.58M	-1583.28M	0.80M	-1681.16M	-1716.54M	0.56M	-1743.24M	-1770.04M	1.13M	-1764.92M	1.14M	0.04M	-2227.99M
Treasury Shares (Quarter)							0.59M				5.59M	5.31M	5.15M	0.82M	0.82M	9.09M	8.92M	8.74M	11.14M	10.83M

Research Tools

Biocryst Pharmaceuticals Balance Sheet (2010-2026) | BCRX

Create an account

Sign In

Reset Password